Quarterly report · Q3
2413.TEDINET S100Q51B
Period2022-04-01 → 2022-12-31
Filed2023-02-10
StandardIFRS
ConsolidatedYes
Data checks16 of 16 passed
Key figures · 61
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥175.2bn | 2022-04-01 → 2022-12-31 | Cons. | Revenue IFRS |
| Revenue | ¥62.5bn | 2022-10-01 → 2022-12-31d | Cons. | Revenue IFRS |
| Revenue | ¥208.2bn | 2021-04-01 → 2022-03-31 | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥154.2bn | 2021-04-01 → 2021-12-31 | Cons. | Revenue IFRS |
| Revenue | ¥56.5bn | 2021-10-01 → 2021-12-31d | Cons. | Revenue IFRS |
| Operating income | ¥58.7bn | 2022-04-01 → 2022-12-31 | Cons. | Operating profit loss IFRS |
| Operating income | ¥22.4bn | 2022-10-01 → 2022-12-31d | Cons. | Operating profit loss IFRS |
| Operating income | ¥84.6bn | 2021-04-01 → 2021-12-31 | Cons. | Operating profit loss IFRS |
| Operating income | ¥22.7bn | 2021-10-01 → 2021-12-31d | Cons. | Operating profit loss IFRS |
| Profit before tax | ¥60.2bn | 2022-04-01 → 2022-12-31 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥22.2bn | 2022-10-01 → 2022-12-31d | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥96.2bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥85.2bn | 2021-04-01 → 2021-12-31 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥22.9bn | 2021-10-01 → 2021-12-31d | Cons. | Profit loss before tax IFRS |
| Net income (owners) | ¥39.3bn | 2022-04-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥15.2bn | 2022-10-01 → 2022-12-31d | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥63.8bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥56.2bn | 2021-04-01 → 2021-12-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥15.4bn | 2021-10-01 → 2021-12-31d | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income | ¥41.8bn | 2022-04-01 → 2022-12-31 | Cons. | Profit loss IFRS |
| Net income | ¥15.9bn | 2022-10-01 → 2022-12-31d | Cons. | Profit loss IFRS |
| Net income | ¥58.5bn | 2021-04-01 → 2021-12-31 | Cons. | Profit loss IFRS |
| Net income | ¥15.8bn | 2021-10-01 → 2021-12-31d | Cons. | Profit loss IFRS |
| Total assets | ¥380.7bn | at 2022-12-31 | Cons. | Assets IFRS |
| Total assets | ¥346.0bn | at 2022-03-31 | Cons. | Assets IFRS |
| Total assets | ¥324.8bn | at 2021-12-31 | Cons. | Total assets IFRS (5-year summary) |
| Total liabilities | ¥83.4bn | at 2022-12-31 | Cons. | Liabilities IFRS |
| Total liabilities | ¥82.0bn | at 2022-03-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥297.4bn | at 2022-12-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥264.0bn | at 2022-03-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥252.7bn | at 2021-12-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥207.3bn | at 2021-03-31d | Cons. | Equity IFRS |
| Equity (owners) | ¥290.7bn | at 2022-12-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥257.8bn | at 2022-03-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥246.6bn | at 2021-12-31 | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Cash & equivalents | ¥109.8bn | at 2022-12-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥104.3bn | at 2022-03-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥95.3bn | at 2021-12-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥89.1bn | at 2021-03-31d | Cons. | Cash and cash equivalents IFRS |
| Operating cash flow | ¥33.4bn | 2022-04-01 → 2022-12-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥52.1bn | 2021-04-01 → 2022-03-31 | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥31.0bn | 2021-04-01 → 2021-12-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Investing cash flow | −¥8.6bn | 2022-04-01 → 2022-12-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥23.4bn | 2021-04-01 → 2022-03-31 | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥10.1bn | 2021-04-01 → 2021-12-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Financing cash flow | −¥20.7bn | 2022-04-01 → 2022-12-31 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥16.4bn | 2021-04-01 → 2022-03-31 | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | −¥15.6bn | 2021-04-01 → 2021-12-31 | Cons. | Net cash provided by used in financing activities IFRS |
| EPS (basic) | ¥57.86 | 2022-04-01 → 2022-12-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥22.42 | 2022-10-01 → 2022-12-31d | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥94.06 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥82.75 | 2021-04-01 → 2021-12-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥22.66 | 2021-10-01 → 2021-12-31d | Cons. | Basic earnings loss per share IFRS |
| EPS (diluted) | ¥57.82 | 2022-04-01 → 2022-12-31 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥22.4 | 2022-10-01 → 2022-12-31d | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥93.98 | 2021-04-01 → 2022-03-31 | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥82.68 | 2021-04-01 → 2021-12-31 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥22.64 | 2021-10-01 → 2021-12-31d | Cons. | Diluted earnings loss per share IFRS |
| Equity ratio | 76.4% | at 2022-12-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 74.5% | at 2022-03-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 75.9% | at 2021-12-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 107
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-12-31 | −¥3.9bn |
| Reconciling Itemsreconciling | revenue | 2022-10-01 → 2022-12-31 | −¥1.1bn |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-12-31 | −¥3.9bn |
| Reconciling Itemsreconciling | revenue intersegment | 2022-10-01 → 2022-12-31 | −¥1.1bn |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-12-31 | −¥1.1bn |
| Reconciling Itemsreconciling | segment profit | 2022-10-01 → 2022-12-31 | −¥418m |
| jpcrp040300-q3r_E05425-000Career Solutionreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥11.5bn |
| jpcrp040300-q3r_E05425-000Career Solutionreportable segment | revenue | 2022-10-01 → 2022-12-31 | ¥3.1bn |
| jpcrp040300-q3r_E05425-000Career Solutionreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥10.8bn |
| jpcrp040300-q3r_E05425-000Career Solutionreportable segment | revenue external | 2022-10-01 → 2022-12-31 | ¥2.9bn |
| jpcrp040300-q3r_E05425-000Career Solutionreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥623m |
| jpcrp040300-q3r_E05425-000Career Solutionreportable segment | revenue intersegment | 2022-10-01 → 2022-12-31 | ¥178m |
| jpcrp040300-q3r_E05425-000Career Solutionreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥4.2bn |
| jpcrp040300-q3r_E05425-000Career Solutionreportable segment | segment profit | 2022-10-01 → 2022-12-31 | ¥734m |
| jpcrp040300-q3r_E05425-000Evidence Solutionreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥20.6bn |
| jpcrp040300-q3r_E05425-000Evidence Solutionreportable segment | revenue | 2022-10-01 → 2022-12-31 | ¥6.6bn |
| jpcrp040300-q3r_E05425-000Evidence Solutionreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥20.1bn |
| jpcrp040300-q3r_E05425-000Evidence Solutionreportable segment | revenue external | 2022-10-01 → 2022-12-31 | ¥6.4bn |
| jpcrp040300-q3r_E05425-000Evidence Solutionreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥521m |
| jpcrp040300-q3r_E05425-000Evidence Solutionreportable segment | revenue intersegment | 2022-10-01 → 2022-12-31 | ¥174m |
| jpcrp040300-q3r_E05425-000Evidence Solutionreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥6.0bn |
| jpcrp040300-q3r_E05425-000Evidence Solutionreportable segment | segment profit | 2022-10-01 → 2022-12-31 | ¥1.8bn |
| jpcrp040300-q3r_E05425-000Medical Platformreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥69.8bn |
| jpcrp040300-q3r_E05425-000Medical Platformreportable segment | revenue | 2022-10-01 → 2022-12-31 | ¥27.2bn |
| jpcrp040300-q3r_E05425-000Medical Platformreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥67.4bn |
| jpcrp040300-q3r_E05425-000Medical Platformreportable segment | revenue external | 2022-10-01 → 2022-12-31 | ¥26.5bn |
| jpcrp040300-q3r_E05425-000Medical Platformreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥2.4bn |
| jpcrp040300-q3r_E05425-000Medical Platformreportable segment | revenue intersegment | 2022-10-01 → 2022-12-31 | ¥739m |
| jpcrp040300-q3r_E05425-000Medical Platformreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥32.1bn |
| jpcrp040300-q3r_E05425-000Medical Platformreportable segment | segment profit | 2022-10-01 → 2022-12-31 | ¥13.3bn |
| jpcrp040300-q3r_E05425-000Overseasreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥47.3bn |
| jpcrp040300-q3r_E05425-000Overseasreportable segment | revenue | 2022-10-01 → 2022-12-31 | ¥17.1bn |
| jpcrp040300-q3r_E05425-000Overseasreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥47.2bn |
| jpcrp040300-q3r_E05425-000Overseasreportable segment | revenue external | 2022-10-01 → 2022-12-31 | ¥17.1bn |
| jpcrp040300-q3r_E05425-000Overseasreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥21m |
| jpcrp040300-q3r_E05425-000Overseasreportable segment | revenue intersegment | 2022-10-01 → 2022-12-31 | ¥17m |
| jpcrp040300-q3r_E05425-000Overseasreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥13.9bn |
| jpcrp040300-q3r_E05425-000Overseasreportable segment | segment profit | 2022-10-01 → 2022-12-31 | ¥5.8bn |
| jpcrp040300-q3r_E05425-000Site Solutionreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥27.5bn |
| jpcrp040300-q3r_E05425-000Site Solutionreportable segment | revenue | 2022-10-01 → 2022-12-31 | ¥8.8bn |
| jpcrp040300-q3r_E05425-000Site Solutionreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥27.2bn |
| jpcrp040300-q3r_E05425-000Site Solutionreportable segment | revenue external | 2022-10-01 → 2022-12-31 | ¥8.8bn |
| jpcrp040300-q3r_E05425-000Site Solutionreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥304m |
| jpcrp040300-q3r_E05425-000Site Solutionreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥3.2bn |
| jpcrp040300-q3r_E05425-000Site Solutionreportable segment | segment profit | 2022-10-01 → 2022-12-31 | ¥917m |
| —segment total | revenue | 2022-04-01 → 2022-12-31 | ¥176.6bn |
| —segment total | revenue | 2022-10-01 → 2022-12-31 | ¥62.7bn |
| —segment total | revenue external | 2022-04-01 → 2022-12-31 | ¥172.8bn |
| —segment total | revenue external | 2022-10-01 → 2022-12-31 | ¥61.6bn |
| —segment total | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥3.8bn |
| —segment total | revenue intersegment | 2022-10-01 → 2022-12-31 | ¥1.1bn |
| —segment total | segment profit | 2022-04-01 → 2022-12-31 | ¥59.5bn |
| —segment total | segment profit | 2022-10-01 → 2022-12-31 | ¥22.6bn |
| Reconciling Itemsreconciling | revenue | 2021-04-01 → 2021-12-31 | −¥3.7bn |
| Reconciling Itemsreconciling | revenue | 2021-10-01 → 2021-12-31 | −¥1.2bn |
| Reconciling Itemsreconciling | revenue intersegment | 2021-04-01 → 2021-12-31 | −¥3.7bn |
| Reconciling Itemsreconciling | revenue intersegment | 2021-10-01 → 2021-12-31 | −¥1.2bn |
| Reconciling Itemsreconciling | segment profit | 2021-04-01 → 2021-12-31 | −¥1.3bn |
| Reconciling Itemsreconciling | segment profit | 2021-10-01 → 2021-12-31 | −¥803m |
| jpcrp040300-q3r_E05425-000Career Solutionreportable segment | revenue | 2021-04-01 → 2021-12-31 | ¥11.0bn |
| jpcrp040300-q3r_E05425-000Career Solutionreportable segment | revenue | 2021-10-01 → 2021-12-31 | ¥2.8bn |
| jpcrp040300-q3r_E05425-000Career Solutionreportable segment | revenue external | 2021-04-01 → 2021-12-31 | ¥10.6bn |
| jpcrp040300-q3r_E05425-000Career Solutionreportable segment | revenue external | 2021-10-01 → 2021-12-31 | ¥2.7bn |
| jpcrp040300-q3r_E05425-000Career Solutionreportable segment | revenue intersegment | 2021-04-01 → 2021-12-31 | ¥465m |
| jpcrp040300-q3r_E05425-000Career Solutionreportable segment | revenue intersegment | 2021-10-01 → 2021-12-31 | ¥102m |
| jpcrp040300-q3r_E05425-000Career Solutionreportable segment | segment profit | 2021-04-01 → 2021-12-31 | ¥4.0bn |
| jpcrp040300-q3r_E05425-000Career Solutionreportable segment | segment profit | 2021-10-01 → 2021-12-31 | ¥582m |
| jpcrp040300-q3r_E05425-000Evidence Solutionreportable segment | revenue | 2021-04-01 → 2021-12-31 | ¥16.2bn |
| jpcrp040300-q3r_E05425-000Evidence Solutionreportable segment | revenue | 2021-10-01 → 2021-12-31 | ¥6.1bn |
| jpcrp040300-q3r_E05425-000Evidence Solutionreportable segment | revenue external | 2021-04-01 → 2021-12-31 | ¥15.5bn |
| jpcrp040300-q3r_E05425-000Evidence Solutionreportable segment | revenue external | 2021-10-01 → 2021-12-31 | ¥5.8bn |
| jpcrp040300-q3r_E05425-000Evidence Solutionreportable segment | revenue intersegment | 2021-04-01 → 2021-12-31 | ¥710m |
| jpcrp040300-q3r_E05425-000Evidence Solutionreportable segment | revenue intersegment | 2021-10-01 → 2021-12-31 | ¥227m |
| jpcrp040300-q3r_E05425-000Evidence Solutionreportable segment | segment profit | 2021-04-01 → 2021-12-31 | ¥3.8bn |
| jpcrp040300-q3r_E05425-000Evidence Solutionreportable segment | segment profit | 2021-10-01 → 2021-12-31 | ¥1.8bn |
| jpcrp040300-q3r_E05425-000Medical Platformreportable segment | revenue | 2021-04-01 → 2021-12-31 | ¥64.7bn |
| jpcrp040300-q3r_E05425-000Medical Platformreportable segment | revenue | 2021-10-01 → 2021-12-31 | ¥26.3bn |
| jpcrp040300-q3r_E05425-000Medical Platformreportable segment | revenue external | 2021-04-01 → 2021-12-31 | ¥62.7bn |
| jpcrp040300-q3r_E05425-000Medical Platformreportable segment | revenue external | 2021-10-01 → 2021-12-31 | ¥25.6bn |
| jpcrp040300-q3r_E05425-000Medical Platformreportable segment | revenue intersegment | 2021-04-01 → 2021-12-31 | ¥2.0bn |
| jpcrp040300-q3r_E05425-000Medical Platformreportable segment | revenue intersegment | 2021-10-01 → 2021-12-31 | ¥674m |
| jpcrp040300-q3r_E05425-000Medical Platformreportable segment | segment profit | 2021-04-01 → 2021-12-31 | ¥30.8bn |
| jpcrp040300-q3r_E05425-000Medical Platformreportable segment | segment profit | 2021-10-01 → 2021-12-31 | ¥14.1bn |
| jpcrp040300-q3r_E05425-000Overseasreportable segment | revenue | 2021-04-01 → 2021-12-31 | ¥37.9bn |
| jpcrp040300-q3r_E05425-000Overseasreportable segment | revenue | 2021-10-01 → 2021-12-31 | ¥13.5bn |
| jpcrp040300-q3r_E05425-000Overseasreportable segment | revenue external | 2021-04-01 → 2021-12-31 | ¥37.8bn |
| jpcrp040300-q3r_E05425-000Overseasreportable segment | revenue external | 2021-10-01 → 2021-12-31 | ¥13.5bn |
| jpcrp040300-q3r_E05425-000Overseasreportable segment | revenue intersegment | 2021-04-01 → 2021-12-31 | ¥17m |
| jpcrp040300-q3r_E05425-000Overseasreportable segment | revenue intersegment | 2021-10-01 → 2021-12-31 | ¥5m |
| jpcrp040300-q3r_E05425-000Overseasreportable segment | segment profit | 2021-04-01 → 2021-12-31 | ¥41.5bn |
| jpcrp040300-q3r_E05425-000Overseasreportable segment | segment profit | 2021-10-01 → 2021-12-31 | ¥3.4bn |
| jpcrp040300-q3r_E05425-000Site Solutionreportable segment | revenue | 2021-04-01 → 2021-12-31 | ¥25.7bn |
| jpcrp040300-q3r_E05425-000Site Solutionreportable segment | revenue | 2021-10-01 → 2021-12-31 | ¥8.2bn |
| jpcrp040300-q3r_E05425-000Site Solutionreportable segment | revenue external | 2021-04-01 → 2021-12-31 | ¥25.2bn |
| jpcrp040300-q3r_E05425-000Site Solutionreportable segment | revenue external | 2021-10-01 → 2021-12-31 | ¥8.0bn |
| jpcrp040300-q3r_E05425-000Site Solutionreportable segment | revenue intersegment | 2021-04-01 → 2021-12-31 | ¥438m |
| jpcrp040300-q3r_E05425-000Site Solutionreportable segment | revenue intersegment | 2021-10-01 → 2021-12-31 | ¥200m |
| jpcrp040300-q3r_E05425-000Site Solutionreportable segment | segment profit | 2021-04-01 → 2021-12-31 | ¥4.6bn |
| jpcrp040300-q3r_E05425-000Site Solutionreportable segment | segment profit | 2021-10-01 → 2021-12-31 | ¥2.0bn |
| —segment total | revenue | 2021-04-01 → 2021-12-31 | ¥155.4bn |
| —segment total | revenue | 2021-10-01 → 2021-12-31 | ¥56.8bn |
| —segment total | revenue external | 2021-04-01 → 2021-12-31 | ¥151.8bn |
| —segment total | revenue external | 2021-10-01 → 2021-12-31 | ¥55.6bn |
| —segment total | revenue intersegment | 2021-04-01 → 2021-12-31 | ¥3.6bn |
| —segment total | revenue intersegment | 2021-10-01 → 2021-12-31 | ¥1.2bn |
| —segment total | segment profit | 2021-04-01 → 2021-12-31 | ¥84.7bn |
| —segment total | segment profit | 2021-10-01 → 2021-12-31 | ¥21.8bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 789
| Item | Context | Value | Unit |
|---|---|---|---|
| Payments for leasehold deposits and guarantee deposits inv cf IFRS | Prior1YTDDuration | -330000000 | JPY |
| Payments for leasehold deposits and guarantee deposits inv cf IFRS | CurrentYTDDuration | -237000000 | JPY |
| Proceeds from collection of leasehold deposits and guarantee deposits inv cf IFRS | Prior1YTDDuration | 229000000 | JPY |
| Proceeds from collection of leasehold deposits and guarantee deposits inv cf IFRS | CurrentYTDDuration | 465000000 | JPY |
| Payments for loans receivable inv cf IFRS | Prior1YTDDuration | -1000000 | JPY |
| Payments for loans receivable inv cf IFRS | CurrentYTDDuration | -4000000 | JPY |
| Collection of loans receivable inv cf IFRS | Prior1YTDDuration | 535000000 | JPY |
| Collection of loans receivable inv cf IFRS | CurrentYTDDuration | 13000000 | JPY |
| Payments for acquisition of subsidiaries inv cf IFRS | Prior1YTDDuration | -1540000000 | JPY |
| Payments for acquisition of subsidiaries inv cf IFRS | CurrentYTDDuration | -12492000000 | JPY |
| Proceeds from sale of subsidiaries inv cf IFRS | Prior1YTDDuration | 1218000000 | JPY |
| Proceeds from sale of subsidiaries inv cf IFRS | CurrentYTDDuration | － | JPY |
| Purchase of investments accounted for using equity method inv cf IFRS | Prior1YTDDuration | -480000000 | JPY |
| Purchase of investments accounted for using equity method inv cf IFRS | CurrentYTDDuration | -1021000000 | JPY |
| Payments for acquisition of businesses inv cf IFRS | Prior1YTDDuration | -433000000 | JPY |
| Payments for acquisition of businesses inv cf IFRS | CurrentYTDDuration | -2298000000 | JPY |
| Decrease due to loss of control over subsidiaries inv cf IFRS | Prior1YTDDuration | -2986000000 | JPY |
| Decrease due to loss of control over subsidiaries inv cf IFRS | CurrentYTDDuration | － | JPY |
| Other inv cf IFRS | Prior1YTDDuration | 22000000 | JPY |
| Other inv cf IFRS | CurrentYTDDuration | 5000000 | JPY |
| Net cash provided by used in investing activities IFRS | Prior1YTDDuration | -10130000000 | JPY |
| Net cash provided by used in investing activities IFRS | CurrentYTDDuration | -8601000000 | JPY |
| Dividends paid to owners of parent fin cf IFRS | Prior1YTDDuration | -8143000000 | JPY |
| Dividends paid to owners of parent fin cf IFRS | CurrentYTDDuration | -10860000000 | JPY |
| Dividends paid to non controlling interests fin cf IFRS | Prior1YTDDuration | -1541000000 | JPY |
| Dividends paid to non controlling interests fin cf IFRS | CurrentYTDDuration | -1790000000 | JPY |
| Capital contribution from non controlling interests fin cf IFRS | Prior1YTDDuration | － | JPY |
| Capital contribution from non controlling interests fin cf IFRS | CurrentYTDDuration | 140000000 | JPY |
| Payments for acquisition of interests in subsidiaries from non controlling interests fin cf IFRS | Prior1YTDDuration | -3262000000 | JPY |
| Payments for acquisition of interests in subsidiaries from non controlling interests fin cf IFRS | CurrentYTDDuration | -5236000000 | JPY |
| Repayments of borrowings fin cf IFRS | Prior1YTDDuration | -10000000 | JPY |
| Repayments of borrowings fin cf IFRS | CurrentYTDDuration | -240000000 | JPY |
| Repayments of lease obligations fin cf IFRS | Prior1YTDDuration | -2727000000 | JPY |
| Repayments of lease obligations fin cf IFRS | CurrentYTDDuration | -2852000000 | JPY |
| Proceeds from issuance of shares fin cf IFRS | Prior1YTDDuration | 48000000 | JPY |
| Proceeds from issuance of shares fin cf IFRS | CurrentYTDDuration | 72000000 | JPY |
| Other fin cf IFRS | Prior1YTDDuration | 73000000 | JPY |
| Other fin cf IFRS | CurrentYTDDuration | 24000000 | JPY |
| Net cash provided by used in financing activities IFRS | Prior1YTDDuration | -15562000000 | JPY |
| Net cash provided by used in financing activities IFRS | CurrentYTDDuration | -20741000000 | JPY |
| Effect of exchange rate changes on cash and cash equivalents IFRS | Prior1YTDDuration | 859000000 | JPY |
| Effect of exchange rate changes on cash and cash equivalents IFRS | CurrentYTDDuration | 1460000000 | JPY |
| Net increase decrease in cash and cash equivalents IFRS | Prior1YTDDuration | 6139000000 | JPY |
| Net increase decrease in cash and cash equivalents IFRS | CurrentYTDDuration | 5504000000 | JPY |
| Cash and cash equivalents IFRS | Prior2YearInstant | 89144000000 | JPY |
| Cash and cash equivalents IFRS | Prior1YearInstant | 104253000000 | JPY |
| Cash and cash equivalents IFRS | Prior1QuarterInstant | 95282000000 | JPY |
| Cash and cash equivalents IFRS | CurrentQuarterInstant | 109757000000 | JPY |
| Revenue from external customers IFRS | Prior1YTDDuration_jpcrp040300-q3r_E05425-000MedicalPlatformReportableSegmentMember | 62686000000 | JPY |
| Revenue from external customers IFRS | Prior1YTDDuration_jpcrp040300-q3r_E05425-000EvidenceSolutionReportableSegmentMember | 15478000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 16 of 16 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |